Wilson Sonsini Goodrich & Rosati advised SR One Capital Management on the deal.ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA targeting therapeutics, announced the completion of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
